RWB closes Florida divestiture, expected to eliminate over $123M in liabilities, strengthen its balance sheet and refocus on profitable growth.

Red White & Bloom closes Ayurcann acquisition, adding Canadian cannabis brands, manufacturing capacity & national distribution to boost revenue and EBITDA.

RWB’s Emblem assumes Ayurcann’s $1.6M DIP facility and commits up to $3M to support CCAA operations ahead of the planned Ayurcann acquisition

Red White & Bloom’s Emblem won the bid to acquire Ayurcann’s licensed manufacturing, vape and pre-roll brands, and Canada-wide distribution.

RWB appoints Michael Di Brina to its Board effective January 12, 2026, and announces the resignation of founding director Michael Marchese